Cargando…
A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer
Oncolytic viruses have emerged as a novel class of anti-cancer therapeutics with one virus already receiving United States Food and Drug Administration (FDA) approval (talimogene laherparepvec) and many others undergoing testing in clinical trials. These viruses have direct lytic effects on tumor ce...
Autores principales: | LaRocca, Christopher J., Warner, Susanne G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316500/ https://www.ncbi.nlm.nih.gov/pubmed/30400571 http://dx.doi.org/10.3390/biomedicines6040104 |
Ejemplares similares
-
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018) -
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models
por: Kim, Sang-In, et al.
Publicado: (2020) -
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
por: Sivanandam, Venkatesh, et al.
Publicado: (2019) -
Oncolytic Virotherapy Increases the Detection of Microscopic Metastatic Disease at Time of Staging Laparoscopy for Pancreatic Adenocarcinoma
por: LaRocca, Christopher J., et al.
Publicado: (2016) -
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
por: Salzwedel, Amanda O., et al.
Publicado: (2018)